Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25845
Title: A Post Hoc Analysis of Osmotherapy Use in the Erythropoietin in Traumatic Brain Injury Study-Associations With Acute Kidney Injury and Mortality.
Austin Authors: Skrifvars, Markus B;Bailey, Michael;Moore, Elizabeth;Mårtensson, Johan;French, Craig;Presneill, Jeffrey;Nichol, Alistair;Little, Lorraine;Duranteau, Jacques;Huet, Olivier;Haddad, Samir;Arabi, Yaseen M;McArthur, Colin;Cooper, David James;Bendel, Stepani;Bellomo, Rinaldo 
Affiliation: Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
Division of Intensive Care, Department of Anaesthesiology, Intensive Care and Pain Medicine, Helsinki University Hospital and University of Helsinki, Finland
Department of Emergency Care and Services, Helsinki University Hospital and University of Helsinki, Finland
Centre for Integrated Critical Care, The University of Melbourne, Melbourne, VIC, Australia
Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
Department of Physiology and Pharmacology, Section of Anaesthesia and Intensive Care, Karolinska Institutet, Stockholm, Sweden
Department of Intensive Care, Western Health, Melbourne, VIC, Australia
Department of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia
School of Medicine and Medical Sciences, University College Dublin, Dublin, Ireland
St Vincent's University Hospital, Dublin, Ireland
Department of Intensive Care and Hyperbaric Medicine, The Alfred, Melbourne, VIC, Australia
Department of Anaesthesia and Intensive Care, Hôpitaux universitaires Paris Sud (HUPS), Université Paris Sud XI, Paris, France
Departement d'anesthésie-réanimation, Hopital de la Cavale Blanche, Boulevard Tanguy Prigent, CHRU de Brest, Univeristé de Bretagne Occidental, Brest, France
King Saud Bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
Department of Critical Care Medicine, Auckland City Hospital, Auckland, New Zealand
Department of Anesthesiology and Intensive Care, Kuopio University Hospital & University of Eastern Finland, Kuopio, Finland
Intensive Care
Issue Date: 1-Apr-2021
Date: 2021-01-20
Publication information: Critical Care Medicine 2021; 49(4): e394-e403
Abstract: Mannitol and hypertonic saline are used to treat raised intracerebral pressure in patients with traumatic brain injury, but their possible effects on kidney function and mortality are unknown. A post hoc analysis of the erythropoietin trial in traumatic brain injury (ClinicalTrials.gov NCT00987454) including daily data on mannitol and hypertonic saline use. Twenty-nine university-affiliated teaching hospitals in seven countries. A total of 568 patients treated in the ICU for 48 hours without acute kidney injury of whom 43 (7%) received mannitol and 170 (29%) hypertonic saline. None. We categorized acute kidney injury stage according to the Kidney Disease Improving Global Outcome classification and defined acute kidney injury as any Kidney Disease Improving Global Outcome stage-based changes from the admission creatinine. We tested associations between early (first 2 d) mannitol and hypertonic saline and time to acute kidney injury up to ICU discharge and death up to 180 days with Cox regression analysis. Subsequently, acute kidney injury developed more often in patients receiving mannitol (35% vs 10%; p < 0.001) and hypertonic saline (23% vs 10%; p < 0.001). On competing risk analysis including factors associated with acute kidney injury, mannitol (hazard ratio, 2.3; 95% CI, 1.2-4.3; p = 0.01), but not hypertonic saline (hazard ratio, 1.6; 95% CI, 0.9-2.8; p = 0.08), was independently associated with time to acute kidney injury. In a Cox model for predicting time to death, both the use of mannitol (hazard ratio, 2.1; 95% CI, 1.1-4.1; p = 0.03) and hypertonic saline (hazard ratio, 1.8; 95% CI, 1.02-3.2; p = 0.04) were associated with time to death. In this post hoc analysis of a randomized controlled trial, the early use of mannitol, but not hypertonic saline, was independently associated with an increase in acute kidney injury. Our findings suggest the need to further evaluate the use and choice of osmotherapy in traumatic brain injury.
URI: https://ahro.austin.org.au/austinjspui/handle/1/25845
DOI: 10.1097/CCM.0000000000004853
Journal: Critical Care Medicine
PubMed URL: 33566466
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

40
checked on May 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.